when fda approve compass pathways' comp360 psilocybin
Before Mar 1, 2027
when fda approve compass pathways' comp360 psilocybin. Best Yes near 49¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 49¢ · Best No: 58¢ · 1 platform
- Kalshi: Yes 49¢ / No 58¢
LIVE
Before Mar 1, 2027
Volume
$174
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Mar 1, 2027
~258 days left
Category
Culture
Yes
49¢
Kalshi
No
58¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Mar 1, 2027
Time Left258 days
Status● Active
CategoryCulture
Yes
49¢
Kalshi
Payout 2.0x
No
58¢
Kalshi
Payout 1.7x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In